Barbara Weber Revolution Medicines, Inc. (RVMD) insider trading activity

Barbara Weber is of Revolution Medicines, Inc.. Currently has a direct ownership of 13,065 shares of RVMD, which is worth approximately $577,603. The most recent transaction as insider was on Oct 08, 2024, when has been sold 5,200 shares (Common Stock) at a price of $48.02 per share, resulting in proceeds of $249,704. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.1K

28.47% 3M change

17.44% 12M change

Total Value Held $577,603

Barbara Weber Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 08 2024	SELL Open market or private sale	$249,704 $48.02 p/Share	5,200 Reduced 28.47%	13,065 Common Stock
Aug 21 2024	SELL Sale (or disposition) back to the issuer	$81,052 $44.83 p/Share	1,808 Reduced 9.01%	18,265 Common Stock
Jun 20 2024	BUY Grant, award, or other acquisition	-	4,800 Added 18.88%	20,625 Common Stock
Sep 01 2023	SELL Open market or private sale	$526,050 $35.07 p/Share	15,000 Reduced 48.66%	15,825 Common Stock
Sep 01 2023	BUY Exercise of conversion of derivative security	$43,950 $2.93 p/Share	15,000 Added 32.73%	30,825 Common Stock
Jun 08 2023	BUY Grant, award, or other acquisition	-	5,200 Added 24.73%	15,825 Common Stock
Jun 16 2022	BUY Grant, award, or other acquisition	-	5,200 Added 32.86%	10,625 Common Stock
Jun 22 2021	BUY Grant, award, or other acquisition	-	3,617 Added 40.0%	5,425 Common Stock
Feb 04 2021	SELL Open market or private sale	$254,700 $50.94 p/Share	5,000 Reduced 73.44%	1,808 Common Stock
Feb 04 2021	BUY Exercise of conversion of derivative security	$23,650 $4.73 p/Share	5,000 Added 42.34%	6,808 Common Stock
Feb 02 2021	SELL Open market or private sale	$240,120 $45.0 p/Share	5,336 Reduced 74.69%	1,808 Common Stock
Feb 02 2021	BUY Exercise of conversion of derivative security	$5,976 $1.12 p/Share	5,336 Added 42.76%	7,144 Common Stock
Dec 30 2020	SELL Open market or private sale	$219,523 $41.14 p/Share	5,336 Reduced 74.69%	1,808 Common Stock
Dec 30 2020	BUY Exercise of conversion of derivative security	$5,976 $1.12 p/Share	5,336 Added 42.76%	7,144 Common Stock
Oct 05 2020	SELL Open market or private sale	$260,279 $36.17 p/Share	7,196 Reduced 79.92%	1,808 Common Stock
Oct 05 2020	BUY Exercise of conversion of derivative security	$8,060 $1.12 p/Share	7,196 Added 44.42%	9,004 Common Stock
Oct 02 2020	SELL Open market or private sale	$28,960 $36.02 p/Share	804 Reduced 30.78%	1,808 Common Stock
Oct 02 2020	BUY Exercise of conversion of derivative security	$900 $1.12 p/Share	804 Added 23.54%	2,612 Common Stock
Oct 01 2020	SELL Open market or private sale	$69,520 $34.76 p/Share	2,000 Reduced 52.52%	1,808 Common Stock
Oct 01 2020	BUY Exercise of conversion of derivative security	$2,240 $1.12 p/Share	2,000 Added 34.44%	3,808 Common Stock

Also insider at

TNGX

Tango Therapeutics, Inc. Healthcare

Chief Executive Officer

Barbara Weber

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVMD shares.

Notify only if

Value

Insider Trading

Get notified when an Revolution Medicines, Inc. insider buys or sells RVMD shares.

Notify only if

Operation

Value

Type

News

Receive news related to Revolution Medicines, Inc.

Track Activities on RVMD

Account